DiaCarta, Inc.
Improving patient care through novel precision molecular diagnostics: CE/IVD marked tests are available for detection of KRAS, NRAS, EGFR, BRAF, PIK3CA, JAK2 . HPV QuantiVirus(r) cervical and head-neck cancer tests allow detection of oncogenic E6/E7 mRNAs from 14 high-risk subtypes and genotyping of HPV 16 and 18, in one simple assay.
United States
Founded in 2010
diacarta.comInaccurate data? Flag it here.Open jobs at DiaCarta, Inc.